4.7 Article

Development of amphiphilic, enzymatically-degradable PEG-peptide conjugate as cell crosslinker for spheroid formation

期刊

COLLOIDS AND SURFACES B-BIOINTERFACES
卷 101, 期 -, 页码 223-227

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2012.06.033

关键词

Cell crosslinker; Oleyl-polyethylene glycol; Peptide; Enzymatic degradation; HepG2; Spheriod

资金

  1. Ministry of Education, Culture, Sports, Science and Technology (MEXT) of japan [21659074]
  2. World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan
  3. Grants-in-Aid for Scientific Research [21659074] Funding Source: KAKEN

向作者/读者索取更多资源

In this study, we developed a novel kind of PEG-peptide conjugated cell crosslinker which is composed of amphiphilic oleyl-polyethylene glycol (PEG) derivatives conjugated with an enzymatically degradable peptide. The oleyl groups at both ends of the polymer chain act as anchoring moiety which can incorporate into cell membrane bilayer via hydrophobic interaction while the incorporation of the peptide sequence in the polymer chain renders the cell crosslinker enzymatically degradable. The average molecular weight, critical micelle concentration of the crosslinker was systematically characterized by gel permeation chromatography, fluorescence method and the crosslinker was shown to be readily cleaved by collagenase. HepG2 cells spheroids formation was observed when the cell crosslinker was added. The number of cells kept increasing over the culture period in the presence of cell crosslinker, suggesting its improved cytocompatibility. With the addition of cell crosslinker, the liver-specific functions of HepG2, such as ammonia elimination, albumin secretion, was enhanced by 1.9 times and 3.0 times on 7th day culture, respectively. Fluorescence microscopy showed more distinct and intense albumin staining in spheroids with cell crosslinker than that without crosslinker. This novel kind of cell crosslinker will be a promising material for tissue engineering and regenerative medicine. (C) 2012 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据